SEC Filings

  
Filing Description Date Filed Sorted Descending Size  
424B3 prospectus filed pursuant to rule 424 Mar 8, 2010 15.3 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Mar 5, 2010 37.7 KB Add to Briefcase
8-K current report Mar 3, 2010 29.9 KB Add to Briefcase
4 nagler, david Mar 2, 2010 19.5 KB Add to Briefcase
4 druzgala, pascal Mar 1, 2010 19.7 KB Add to Briefcase
4 varian, john Mar 1, 2010 19.6 KB Add to Briefcase
4 milner, peter g Mar 1, 2010 19.6 KB Add to Briefcase
4 goddard, paul Mar 1, 2010 19.5 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Feb 23, 2010 53.2 KB Add to Briefcase
8-K current report Feb 19, 2010 44.7 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 33.3 KB Add to Briefcase
SC 13G statement of beneficial ownership Feb 12, 2010 19.6 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 16.7 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 31.7 KB Add to Briefcase
5 nagler david Feb 11, 2010 21.7 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 5, 2010 31.7 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Jan 20, 2010 15.1 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Jan 5, 2010 53.8 KB Add to Briefcase
8-K current report Jan 5, 2010 45.1 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Dec 30, 2009 15.7 KB Add to Briefcase
Showing 1-20 of 168 Page: 1 2 3 ... 9  Next 20
Add to Briefcase = add filing to Briefcase
Stock Information
NASDAQ:ARYX
$1.19   - 0.01 		Mar 9, 2010
4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
 ARYx Therapeutics Final
     Prospectus

Corporate Presentation

Learn more about our products, technology, and financial history by viewing our Corporate Presentation.

Learn More